Bimatoprost is a synthetic prostaglandin analog primarily used to reduce intraocular pressure in conditions like glaucoma and ocular hypertension. It works by increasing the outflow of aqueous humor from the eye, thereby helping to prevent damage to the optic nerve. It is commonly marketed under the brand name Lumigan for medical use, and as Latisse for enhancing eyelash growth. The drug was developed in the late 20th century during research on prostaglandin-related compounds and was approved by the U.S. Food and Drug Administration in 2001 for treating glaucoma. During clinical trials, increased eyelash growth was observed as a side effect, which led to its additional approval in 2008 for cosmetic purposes. Since then, bimatoprost has gained widespread use in both ophthalmology and cosmetic treatments, making it a versatile and important medication.
BRAND NAMES
Latisse – primarily for eyelash growth
Lumigan – for glaucoma and ocular hypertension
Bimoprost – generic or other regional brands
MECHANISM OF ACTION
For eyelash growth, it stimulates hair follicles, prolonging the growth phase, which makes lashes longer, thicker, and darker.
PHARMACOKINETICS
Absorption
Bimatoprost is rapidly absorbed when applied topically to the eye, with peak concentrations in the aqueous humor occurring within 1–2 hours. Only a small amount enters systemic circulation, and plasma levels are generally low, minimizing systemic effects.
Distribution
After topical ocular application, bimatoprost is primarily concentrated in the eye tissues, including the cornea, conjunctiva, and aqueous humor. Systemic distribution is minimal, and the drug does not significantly accumulate in other organs, keeping systemic exposure low.
Metabolism
Bimatoprost is minimally metabolized in the body. In the eye, it is hydrolyzed to its free acid form, which is active. Any small amount that enters systemic circulation is primarily metabolized in the liver through oxidation, N-deethylation, and glucuronidation before being excreted.
Excretion
Bimatoprost and its metabolites are primarily excreted in the urine, with a smaller amount eliminated in the feces. The drug has a short systemic half-life of about 45 minutes, so it does not accumulate significantly in the body.
PHARMACODYNAMICS
Bimatoprost lowers eye pressure by increasing the outflow of aqueous humor and stimulates eyelash follicles to prolong the growth phase, resulting in longer, thicker, and darker lashes, with minimal systemic effects.
ADMINISTRATION
Bimatoprost is applied topically as an eye drop for glaucoma or ocular hypertension, usually once daily in the evening. For eyelash growth, it is applied once daily to the base of the upper eyelashes using the provided applicator, taking care to avoid contact with the eyes or lower lashes.
DOSAGE AND STRENGTH
For Glaucoma/Ocular Hypertension: 0.01% or 0.03% ophthalmic solution, 1 drop in the affected eye(s) once daily in the evening.
For Eyelash Growth (Latisse): 0.03% solution, applied once daily to the base of the upper eyelashes using the supplied applicator.
FOOD INTERACTIONS
Its effectiveness is not affected by meals, and it can be used regardless of food intake.
DRUG INTERACTIONS
Bimatoprost has minimal systemic absorption, so interactions are uncommon. However, using it with other prostaglandin eye drops may reduce its effectiveness, and different ophthalmic medications should be applied at least 5 minutes apart.
CONTRAINDICATIONS
Bimatoprost is contraindicated in individuals with known hypersensitivity to the drug or its components. It should be used with caution in patients with eye infections, inflammation, or a history of macular edema, as it may worsen these conditions.
SIDE EFFECTS
Common side effects of bimatoprost include eye redness, itching, dryness, and irritation. It may also cause darkening of the iris, eyelid skin pigmentation, and increased eyelash growth. Less commonly, patients may experience eye pain, blurred vision, or swelling.
TOXICITY
Bimatoprost has low systemic toxicity due to minimal absorption. Excessive use may cause eye irritation, redness, and inflammation, while long-term use can lead to permanent iris pigmentation and reversible eyelid darkening.
